Pregnancy as a window to the future: outcomes of antihypertensive therapy and superimposed preeclampsia in pregnant women with mild chronic hypertension (chap maternal follow-up study)

Active Project Grant Awarded Last action

Award ID
R01HL120338
Recipient
Awarding agency
Obligated
$26,344,761

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date 94% complete
Originally
Funding
  • $23,991,856.00 Federal
  • $2,352,905.00 Non-federal
Place of performance
Irondale, AL 35210, USA

Award details come from USAspending.gov.

Description

Abstract
The large randomized multicenter chronic hypertension and pregnancy (CHAP) trial (2015-2021) was designed to evaluate the short-term benefits and safety of pharmacologic treatment of pregnant women with mild chronic hypertension (CHTN). This proposed CHAP maternal follow-up project (2021-2026) is a follow-up study of the well-characterized women in CHAP to address the critical knowledge gaps regarding whether future long-term cardiovascular disease (CVD) and other outcomes are associated with 1) antihypertensive therapy use early in pregnancy and 2) the development of superimposed preeclampsia (SI pre). CHTN is the most common major medical disorder seen in pregnancy, is most often mild (i.e. BP

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $2,007,149 $0
Amendment $1,976,808 $0
Amendment $2,046,886 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $2,103,237 $0
Amendment $2,103,237 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $2,262,182 $0
Amendment $2,262,182 $0
Amendment $2,262,182 $0
Amendment $2,262,182 $0
Amendment -$2,302,071 $0
Amendment -$2,302,071 $0
Amendment -$2,302,071 $0
Amendment -$2,302,071 $0
Amendment $2,302,071 $0
Amendment $2,302,071 $0
Amendment $2,302,071 $0
Amendment $2,302,071 $0
Amendment $2,352,905 $0
Original award $2,352,905 $2,352,905
Show all 27

Subawards

Subrecipient Amount Awarded
Old Dominion University Research Foundation Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP… $35,509
The Medical College Of Wisconsin, Inc. $41,774
Ochsner Clinic Foundation $58,528
Denver Health And Hospital Authority $43,251
Baylor College Of Medicine $46,004
Weill Medical College Of Cornell University $42,113
The Metrohealth System $25,966
The Trustees Of Columbia University In The City Of New York $94,698
Duke University $65,059
University Of South Alabama $43,456
University Of Texas Medical Branch At Galveston $25,689
University Of Kansas Medical Center Research Institute, Inc. $24,920
University Of Oklahoma $24,199
The Regents Of The University Of California. San Francisco CHAP maternal follow-up study $2,342
University Of North Carolina At Chapel Hill Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP… $72,247
University Of North Carolina At Chapel Hill CHAP maternal follow-up study $6,765
Saint Luke's Hospital Of Bethlehem, Pennsylvania Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP… $20,007
The Washington University Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP… $23,669
University Of Texas Health Science Center At Houston Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP… $25,665
The Regents Of The University Of Colorado $20,493
The Administrators Of Tulane Educational Fund Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP… $26,928
Yale Univ Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP… $27,177
The Leland Stanford Junior University Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP… $32,542
The Regents Of The University Of California. San Francisco $23,313
Oregon Health & Science University $24,150
University Of Mississippi Medical Center $17,487
University Of Utah $45,878
The Trustees Of The University Of Pennsylvania $67,847
Miami Valley Hospital $12,780
Duke University $25,412
The Regents Of The University Of California. San Francisco $47,885
University Of North Carolina At Chapel Hill $48,726
The Medical College Of Wisconsin, Inc. $35,647
Ochsner Clinic Foundation $59,234
University Of Texas Health Science Center At Houston $69,005
The Washington University $48,874
University Of Texas Medical Branch At Galveston $57,289
The Leland Stanford Junior University $43,481
Baylor College Of Medicine $45,802
The Trustees Of The University Of Pennsylvania $70,207
The Metrohealth System Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP… $58,466
Denver Health And Hospital Authority Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP… $23,305
University Of South Alabama $48,943
The Administrators Of Tulane Educational Fund $41,818
Yale Univ $60,677
Saint Luke's Hospital Of Bethlehem, Pennsylvania $39,557
University Of Kansas Medical Center Research Institute, Inc. $40,305
University Of Utah $84,253
University Of Mississippi Medical Center $63,992
The Regents Of The University Of Colorado $44,179
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Quick answers

Who received award R01HL120338?

R01HL120338 was awarded to University Of Alabama At Birmingham by National Heart Lung and Blood Institute (National Institutes of Health) on September 1, 2014.

How much is award R01HL120338 worth?

$26,344,761 has been obligated on R01HL120338: $23,991,856 in federal funding and $2,352,905 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award